Fortner JH et al. |
Tapetal effect of an azalide antibiotic following oral administration in beagle dogs. |
1993 |
Fundam Appl Toxicol |
pmid:8405779
|
Bailey RL et al. |
Randomised controlled trial of single-dose azithromycin in treatment of trachoma. |
1993 |
Lancet |
pmid:8102427
|
Narcio Reyes LE et al. |
[Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections]. |
1993 |
Ginecol Obstet Mex |
pmid:8406112
|
Donowitz GR and Earnhardt KI |
Azithromycin inhibition of intracellular Legionella micdadei. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285604
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Brown ST et al. |
Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8384809
|
Hammerschlag MR et al. |
Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. |
1993 |
J. Pediatr. |
pmid:8388950
|
Kobrehel G et al. |
9a,11-cyclic carbamates of 15-membered azalides. |
1993 |
J. Antibiot. |
pmid:8407586
|
Bonnet M and Van der Auwera P |
Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390808
|
Gordillo ME et al. |
In vitro activity of azithromycin against bacterial enteric pathogens. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390813
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Saba J et al. |
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8112357
|
Weiss LM et al. |
Efficacy of azithromycin for treating Babesia microti infection in the hamster model. |
1993 |
J. Infect. Dis. |
pmid:8228366
|
Lefèvre JC et al. |
In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. |
1993 |
Pathol. Biol. |
pmid:8233628
|
Rodewald LE and Pichichero ME |
Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports. |
1993 |
J. Pediatr. |
pmid:8391566
|
Vargas SL et al. |
Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer. |
1993 |
J. Pediatr. |
pmid:8391567
|
Gingras BA and Jensen JB |
Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. |
1993 |
Am. J. Trop. Med. Hyg. |
pmid:8394660
|
Mansoor GA et al. |
Azithromycin-induced acute interstitial nephritis. |
1993 |
Ann. Intern. Med. |
pmid:8395778
|